TABLE 1.

Association between the expression levels of RIP3 and clinic pathological features in prostate cancer.

Characteristic	Patients Number	RIP3 Expression Level		P
		Low (%)	High (%)
Nomal vs Cancer				0.001***
Normal	21	3 (14.3)	18 (85.7)
Cancer	84	45 (53.6)	39 (46.4)
PSA Level				0.330
<10	9	5 (55.6)	4 (44.4)
10–50	36	16 (44.4)	20 (55.6)
>50	39	24 (61.5)	15 (38.5)
Gleason				0.739
< = 7	35	18 (51.4)	17 (48.6)
>7	49	27 (55.1)	22 (44.9)
Tumor metastasis				0.01*
Metastasis	38	26 (68.4)	12 (31.6)
Non-metastatic	45	18 (40.0)	27 (60.0)
Unknown	1
Biochemical recurrence
Yes	40	25 (62.5)	15 (37.5)	0.118
No	44	20 (45.5)	24 (54.5)